Nav: Home

Digital PCR shows high reproducibility in international multicenter study

March 14, 2017

HERCULES, Calif. -- March 14, 2017 -- Twenty-one independent laboratories quantified a rare single nucleotide variant using digital PCR (dPCR) with high reproducibility between labs, demonstrating the method's potential for routine clinical testing, according to a study published in Analytical Chemistry.

The study is the first to examine the reproducibility of digital PCR, an approach to quantifying nucleic acids that partitions samples into thousands of smaller reactions, between such a large number of laboratories at different geographic locations. The findings illustrate the inherent potential advantages of dPCR in measuring clinically important mutations, including greater reproducibility and less variability than real-time quantitative PCR (qPCR). In addition, the findings highlight the ability of dPCR to detect relevant rare sequence variants, according to the authors.

"Digital PCR lends itself to clinical testing where precise and reproducible results are critical not only for interlab data comparability, but also for dynamic testing in the same lab to track disease progression," said George Karlin-Neumann, co-author and Director of Scientific Affairs at Bio-Rad's Digital Biology Group.

The method permits precise and accurate quantification of nucleic acid concentration by minimizing the variability from common sources of error that can influence qPCR results. These sources include PCR inhibitors that can alter assay efficiency and skew standard curves. Digital PCR also provides absolute quantification of target nucleic acids without the need to establish standard curves, a major source of variability in qPCR.

The blinded study was part of the BioSITrace project, coordinated by the Laboratory of the Government Chemist (LGC), a private life sciences measurement and testing company and the UK's designated National Measurement Laboratory for chemical and biomeasurement. Researchers in 21 laboratories across North America and Europe were asked to use dPCR to quantify copy number concentrations and fractional abundance of a KRAS mutant DNA with a single nucleotide variation (G12D) in the presence of excess wild-type DNA (down to ~0.2% minor allele frequency). The laboratories performed the experiments using Bio-Rad's Droplet Digital™ PCR (ddPCR™) technology, on either a QX100™ or a QX200™ Droplet Digital PCR System from Bio-Rad. Droplet Digital PCR is Bio-Rad's proprietary method for performing digital PCR in which a sample is divided into 20,000 water-oil emulsion droplets.

Cancer-derived mutations that differ only slightly from a wild-type sequence present in a sample in large excess are particularly difficult to detect and quantify using qPCR, especially when fractional abundance of the mutant is less than 5%.

The results of all 21 laboratories agreed with each other within a rigorously defined margin of error. Though three laboratories initially reported differing results, further analysis revealed methodological error attributed to misclassification of positive and negative droplets rather than measurement error. When the data were reanalyzed according to the recommended guidelines, they generated results consistent with the other 18 labs, validating the potential of dPCR for clinical testing applications.

"The ability to detect and quantify rare single nucleotide variants is another strength of dPCR and a measurement that is difficult to make at all with conventional qPCR," said Karlin-Neumann. "So, similar to the Olympics, the inter-lab study attempted a very difficult 'routine' that, when done well, scores higher marks than a simpler, safer routine."

Toward Clinical Adoption of dPCR

The study supports a new and more robust approach to nucleic acid analysis to address the reproducibility challenges that have plagued the clinical adoption of other PCR-based platforms.

"In the short term, I would anticipate digital PCR will be increasingly used as a reference method to improve the harmonization across laboratories," said Jim Huggett, corresponding author of the article and a Principal Scientist at LGC. "As digital PCR is increasingly used for clinical diagnostics and preclinical research, people will find that they are more easily able to obtain comparable results."
-end-
For more information about Bio-Rad's Droplet Digital PCR technology, please visit bio-rad.com/digital-pcr.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs more than 8,250 people worldwide and had revenues exceeding $2 billion in 2016. For more information, please visit http://www.bio-rad.com.

Bio-Rad

Related Clinical Adoption Articles:

Study reveals low adoption of advice to reduce nuclear cardiology radiation exposure
A study in 65 countries has revealed low adoption of International Atomic Energy Agency recommendations to reduce nuclear cardiology radiation exposure.
Modeling reveals how policy affects adoption of solar energy photovoltaics in California
Researchers at the University of California, Riverside, inspired by efforts to promote green energy, are exploring the factors driving commercial customers in Southern California, both large and small, to purchase and install solar photovoltaic (PV) systems.
Children can benefit when adoptive and biological parents share adoption stories
'Open' adoptions, or adoptions in which adoptive families have ongoing interactions with the birth family are becoming more popular.
Clinical assessment of muscular fatigue
A patient's response to a therapeutic exercise program depends on the effectiveness of the program and the value of its delivery system.
UD researchers look at programs to incentivize cover crop adoption
A new interdisciplinary study led by the University of Delaware and funded by the USDA is going to investigate what aspects of best management practices -- specifically related to cover crops -- farmers in Maryland and Ohio prefer.
Skype data of 500 million people reveals the real patterns of social adoption
Global patterns of adoption spreading are induced by local adoption cascades initiated by multiple spontaneous adopters arriving at a constant rate, amplified by a large number of adoptions induced by social influence, and controlled by individuals who are immune to the actual adoption.
Biosimilars -- clinical perspectives in rheumatology
Rheumatologists from Charité -- Universitätsmedizin Berlin and the University of Massachusetts Medical School have been analyzing clinical data on biosimilars that have already been approved for use.
Adoption of streamlined breast cancer treatment has stagnated, study finds
It was hoped that the development of accelerated partial breast irradiation would increase the number of early-stage breast cancer patients getting radiation treatment.
MD Anderson and Cellectis announce pre-clinical and clinical alliance in cancer immunotherapy
Cellectis, the gene editing company employing proprietary technologies to develop best-in-class CAR T-cell products in adoptive immunotherapy for cancer, and The University of Texas MD Anderson Cancer Center have entered into a research and development alliance aimed at bringing novel cellular immunotherapies to patients suffering from different types of liquid tumors.
What does clinical research at universities in Germany need?
At the annual meeting of the Deutsche Forschungsgemeinschaft on June 30, 2015, the Senate of the largest research funding organization approved recommendations for 'Developing Clinical Research at German Universities Between 2015 and 2025.'

Related Clinical Adoption Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Bias And Perception
How does bias distort our thinking, our listening, our beliefs... and even our search results? How can we fight it? This hour, TED speakers explore ideas about the unconscious biases that shape us. Guests include writer and broadcaster Yassmin Abdel-Magied, climatologist J. Marshall Shepherd, journalist Andreas Ekström, and experimental psychologist Tony Salvador.
Now Playing: Science for the People

#513 Dinosaur Tails
This week: dinosaurs! We're discussing dinosaur tails, bipedalism, paleontology public outreach, dinosaur MOOCs, and other neat dinosaur related things with Dr. Scott Persons from the University of Alberta, who is also the author of the book "Dinosaurs of the Alberta Badlands".